drugset / Trial / NCT01693185

Remifentanil Only vs. Midazolam and Meperidine During Elective Colonoscopy

NCT01693185 ↗

RandomizedParallel-groupSingle-blindTreatment

Summary

The aim of the present study is to compare patient's recovery times after elective colonoscopy employing remifentanil only vs conventional combination of midazolam and meperidine

Timeline

Start
2012-12
Primary completion
2013-02
Completion
2013-08

Outcome

Met primary endpoint

registry Remifentanil vs Midazolam and Meperidine; p < 0.001; Wilcoxon (Mann-Whitney) NCT01693185 ↗

Drugs

EvaluationDrugModalityDoseRoute
Comparator Meperidine Unknown 1 mg/kg Intravenous
Comparator Midazolam Small molecule 0.03 mg/kg Intravenous
Subject Remifentanil Small molecule 0.04 ug/kg Intravenous

Indications

No indication recorded.